The large extent of polymorphism of major histocompatibility complex (*MHC*) genes is believed to be maintained by balancing selection for the extent of the peptide binding repertoire between individuals (Hughes and Nei [@CR3], [@CR4]; Takahata and Nei [@CR17]; Hughes and Yeager [@CR5]). A unique effect of balancing selection is the long persistence time of alleles in populations and, consequently, trans-species polymorphism (Klein [@CR8]; Takahata [@CR16]; Takahata et al. [@CR18]; Klein et al. [@CR9], [@CR10]). However, it is difficult to show direct evidence of such selection by experiments and to measure selection intensity directly. Satta et al. ([@CR14]) estimated the intensity of selection at the human *MHC* (human leukocyte antigen (*HLA*)) loci by using the available collection of allelic sequences and a simple model based on symmetric overdominant selection and the theory of allelic genealogy (Kimura and Crow [@CR7]; Takahata [@CR16]; Takahata and Nei [@CR17]; Takahata et al. [@CR18]).

In recent years, a number of *HLA* allelic nucleotide sequences have become available through IMGT/HLA database (<http://www.ebi.ac.uk/imgt/hla/>, Robinson et al. [@CR12]). Currently (2012), the database contains 7,670 alleles. This large dataset of sequences provides an opportunity to estimate more reliable evolutionary parameters, such as natural selection intensity. Hence, we re-estimated the selection coefficient and compared the estimates with those in the previous study that was based on a limited number of sequences (Satta et al. [@CR14]).

The large number of nucleotide sequences at the six functional *HLA* loci (*HLA-A*, *HLA-B*, *HLA-C*, *HLA-DRB1*, *HLA-DQB1*, and *HLA-DPB1*), which play important roles in peptide presentation, was obtained from the IMGT/HLA database. In addition, nucleotide sequences of alleles at the *HLA* class II A (*DQA1* and *DPA1*) and class II B (*DRB3* and *DRB5*) loci were also used in this analysis. Because the inclusion of recombinants will lead a biased estimation of the selection intensity, possible recombinant alleles were excluded by using the method described by Satta ([@CR13]). This method assumes that the relationship between the number of substitutions in a particular region and the number of substitutions in the entire region is binomially distributed. At the *HLA-B* locus, an exceptionally divergent *HLA-B*\**73*:*01* allele (Abi-Rached et al. [@CR1]), which might have been transmitted to extant humans from a distinct *Homo* by interbreeding, was also excluded from this analysis. Applying the theory of allelic genealogy under symmetric overdominant selection to this analysis, we used only dominant alleles that have a frequency \>1 % throughout various human populations (the NCBI dbMHC database, <http://www.ncbi.nlm.nih.gov/gv/mhc>, Meyer et al. [@CR11]). We also excluded the nucleotide sequences with a wide range of undetermined nucleotides from this analysis (Table [1](#Tab1){ref-type="table"}). Therefore, the number for alleles used in this analysis was limited to 9 *HLA-A* alleles, 19 *HLA-B*, 20 *HLA-C*, 25 *HLA-DRB1*, 13 *HLA-DQB1*, 10 *HLA-DPB1*, 6 *HLA-DQA1*, 3 *HLA-DPA1*, 13 *HLA-DRB3*, and 5 *HLA-DRB5*. These *HLA* alleles are listed in Online Resource [1](#SecESM1){ref-type="sec"}. Interestingly, most of the enormously large numbers of nucleotide sequences in the current database are minor or private alleles.Table 1The number of alleles and dominant alleles in the database*HLA* locusNo. of allelesNo. of PBR in different allelesIn the databaseWholeNonrecombinantDominant^a,\ b^Nonrecombinant^b^Dominant^b^*A*1,5941565027^c^ (18)^d^3226*B*2,12323514340^c^ (21)^d^11339*C*1,10214312920^c^6019*DRB1*975645626 (1)^d^3723*DQB1*144(61)^e^55131310*DPB1*145(44)^e^3811 (1)^d^2311*DRB3*58(13)^e^13−6−*DRB5*20(5)^e^5−4−*DQA1*4734318 (2)^d^95*DPA1*34(11)^e^95 (2)^d^33^a^The number of dominant alleles that have a high frequency (\>1 %) throughout human populations worldwide (including possible recombinants)^b^The number of amino acid sequences^c^The number of dominant alleles that are detected in \>100 chromosomes from \>25 human populations^d^The number of dominant alleles that are excluded due to a possible recombinant or short sequence^e^Not whole coding sequence (see text)

According to the theory described in Takahata ([@CR16]) and Takahata et al. ([@CR18]), to estimate the selection coefficient *s*, two estimators, *γ* and *K*~B~, must be calculated. The estimator *γ* is the ratio of the number of nonsynonymous substitutions per peptide-binding region (PBR) site to that of synonymous substitutions per site among given pairs of alleles, whereas *K*~B~ is the mean number of pairwise nonsynonymous substitutions in the PBR. The number of synonymous and nonsynonymous sites was estimated using the modified Nei--Gojobori method (Zhang et al. [@CR19]) with the Jukes--Cantor correction (Jukes and Cantor [@CR6]). Because of the relatively early ceiling in the number of nonsynonymous substitutions in the PBR due to acceleration of the nucleotide substitution rate by balancing selection, Satta et al. ([@CR14]) developed five methods for estimating *K*~B~, and these methods were evaluated by computer simulations. Here, we used method II because this method minimized errors in the multiple-hit correction (Satta et al. [@CR14]). In this method, selection coefficients can be adequately estimated by using only sets of sequences that are relatively closely related.

The estimated values of *K*~B~ and *γ* at the six major *HLA* loci described above are provided in Table [2](#Tab2){ref-type="table"}. Using these values, we obtained other estimators, *M* and *S*, which were also necessary for estimating the selection coefficient, *s* (see Satta et al. [@CR14]). Assuming that a long-term effective population size of humans is 10^5^, the *s* values of *HLA-B* and *HLA-DRB1* loci (*s* = 4.4 and 1.9 %, respectively) in the present study were the highest for the class I and class II loci, respectively. This result was consistent with that of the previous study (Satta et al. [@CR14]). All *s* values were more or less similar to those of the previous study with the exception of *DQB1* and *DPB1* loci: the current estimate of *DQB1* was lower than the previous estimate and the value for *DPB1* was much higher than the previous estimate (Satta et al. [@CR14]). One possible reason for this is the different set of nucleotides sequences used than the previous study. In fact, both for *DQB1* and *DPB1*, the number of dominant alleles used in the present analysis increases compared to that of the previous one.Table 2Estimates of the mean number of nonsynonymous substitutions, the relative nonsynonymous substitution rate in the PBR, and the selection coefficient (*s*)*HLA* locusLength^a^*L*~*S*~^a^*L*~*B*~^a^*L*~*N*~^a^No. of allele 1^b^No. of allele 2^c^*K*~B~*γSMsA*1,095 bp29512367427^d^928.9 (26.0)7.6 (6.3)4,500 (3,000)0.04 (0.09)2.25 % (1.50 %)*B*1,086 bp30012264340^d^1935.9 (36.0)9.7 (9.0)8,825 (8,200)0.01 (0.02)4.41 % (4.20 %)*C*1,093 bp30112566520^d^2017.3 (15.0)4.9 (3.4)1,030 (530)0.15 (0.29)0.52 % (0.26 %)*DRB1*795 bp22353521262523.2 (25.0)10.2 (9.3)3,890 (3,900)0.01 (0.01)1.94 % (1.90 %)*DQB1*687 bp14851347131312.4 (20.0)4.4 (6.0)479 (1,700)0.14 (0.08)0.24 % (0.85 %)*DPB1*543 bp14653344111011.9 (6.8)9.2 (4.3)918 (140)0.01 (0.08)0.46 % (0.07 %)*DRB3*549 bp14854347(13^e^)−5.6 −5.4 −120 −0.04 −0.06 % −*DRB5*549 bp14853348(5^e^)−8.0 −7.9 −360 −0.01 −0.18 % −*DQA1*765 bp21147504865.9 (13.0)2.1 (4.5)53 (550)0.23 (0.14)0.03 % (0.28 %)*DPA1*663 bp19042428534.8 −3.3 −54 −0.10 −0.03 % −The numbers of sites of synonymous and nonsynonymous substitutions were estimated using the modified Nei--Gojobori model (*R* = 1.04 for class I, *R* = 1.14 for class II). The parameter values in parentheses were estimated on the basis of method II described in Satta ([@CR13]). The mutation rate per PBR per generation (*u*) = 1.7 × 10^−6^ for class I loci and 7.5 × 10^−7^ for class II loci; effective population size (*N*~e~) = 10^5^ (see Satta et al. [@CR14])*L*~*S*~ the number of synonymous sites across the entire region, *L*~*B*~ the number of nonsynonymous sites at the PBR, *L*~*N*~ the number of nonsynonymous sites at the non-PBR^a^The length or the number of sites used in this study (not in the previous study)^b^The number of dominant alleles that have a high frequency (\>1 %) throughout human populations worldwide (shown as *n*~a~ in text)^c^The number of dominant alleles excluding possible recombinants^d^The number of dominant alleles that are detected in \>100 chromosomes from \>25 human populations^e^The number of alleles not derived from the dominant allele because of lack of information about allele frequencies in the human populations

Allelic genealogy predicts that *K*~B~ is approximately equal to the number of dominant alleles (*n*~a~) in a population. In fact, *n*~a~ showed good agreement with *K*~B~ in three class II B loci (Table [2](#Tab2){ref-type="table"}). In class I loci, the *HLA-C* showed relatively good agreement between *n*~a~ and *K*~B~, whereas for the *HLA-A* and *HLA-B* loci, the observed number of dominant alleles was less than the expected number. This discrepancy might indicate that the definition of dominant alleles is inappropriate for class I loci. Originally, we regarded an allele with a frequency of more than 1 % over all populations examined as a dominant allele. According to the dbMHC database, the number of chromosomes examined at all three class I loci was more than 10,000 in total, ranging from allele to allele. Thus, we defined 1 % (100 chromosomes) of 10,000 chromosomes as a class I dominant allele. In addition, the mean number of populations in which class II dominant alleles were observed was about 25. Therefore, for class I loci, we considered the alleles detected on \>100 chromosomes through \>25 populations as a dominant allele. Surprisingly, *n*~a~ of class I loci under this new definition showed good agreement with *K*~B~ (Table [2](#Tab2){ref-type="table"}). This might imply that some dominant alleles, with \<1 % allele frequency in the entire world population, were dominantly distributed throughout the human population until quite recently and that they have decreased in frequency because their alleles might be replaced by other alleles that had an advantage in the modern environments of some populations. The number of different dominant alleles in the PBR also shows good agreement with expectations (Table [1](#Tab1){ref-type="table"}). After the exclusion of possible recombinants, the numbers at each locus were 26 at *HLA-A*, 39 at *HLA-B*, and 19 at *HLA-C*. However, when we included rare alleles, these numbers increased to 32, 113, and 60, respectively. The number of rare alleles which have de novo PBR nonsynonymous mutations is large and they may have emerged by a population expansion quite recently (Fu et al. [@CR2]).

In addition to the above estimates, we further estimated the selection coefficients for *DRB3*, *DRB4*, *DRB5*, *DQA1*, and *DPA1* (Table [2](#Tab2){ref-type="table"}). With the exception of *DRB4* (see below), all selection coefficient *s* of the four *HLA* class II loci were lower than those of the six major *HLA* loci (*HLA-A*, *HLA-B*, *HLA-C*, *HLA-DRB1*, *HLA-DQB1* and *HLA-DPB1*), indicating that the six major loci have been strongly affected by balancing selection. The present *s* estimate of *DQA1* is lower than that of the previous one, but the present *K*~B~ value is similar to the *n*~a~. We consider that the present estimate is close to the true value. For *DRB4*, 15 alleles were deposited in the database and they are identical at the PBR sites and nearly identical at the neutral (synonymous and non-PBR nonsynonymous) sites. Thus, inference of the *γ* and *K*~B~ values is difficult. The relatively recent emergence of *DRB4* (the per site nucleotide divergence from *DRB2* is 0.015∼0.017: Satta et al. [@CR15]) supports this observation. In addition, the small amount of nucleotide divergence at neutral sites for *DRB4* indicates the relatively small effective population size of *DRB4*. This suggests that the frequency of *DR53* haplotype on which *DRB4* resides is relatively lower than that of other *HLA* haplotypes. In addition, *DRB3* and *DRB5* also show the smaller effective size than that of other *HLA* loci (The estimated *N*~e~ values of *DRB3* and *DRB5* are quite smaller than 10^5^). This is also because that *DRB3* and *DRB5* are located on a limited *DR* haplotype, whereas other *HLA* loci exist in all humans.

Our findings show that although the number of sequences in the database has greatly increased in the past 20 years, most of the accumulated sequences are minor or private alleles and the number of dominant alleles does not change largely since the previous estimation. Therefore, most of selection coefficients in the six major *HLA* loci estimated in the present study were similar to those of the previous study. One may consider that application of symmetrical overdominance is too strict for the actual data. However, the simulation study by Takahata and Nei ([@CR17]) reveals that the asymmetrical overdominance model does not fit the mode of polymorphism for actual data: under a given selection coefficient of asymmetrical model, the number of alleles and the average heterozygosity become smaller than those under symmetrical overdominance model. In fact, the number of dominant alleles at all *HLA* loci was consistent with the *K*~B~ values under symmetrical overdominance, suggesting the consistency between our assumed model and the actual data. Therefore, the overdominance model is appropriate to the present estimation. Through this analysis, we confirmed that the selection intensity (selection coefficient, *s*) of *HLA* loci in modern humans is at most 4.4 %, even though *HLA* is the prominent example on which natural selection acts.
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